Anti col 1 antibody

Western blot analysis was performed as previously described [21 (link)]. Macrophages or cementoblasts were washed and solubilized with RIPA lysis buffer. Protein concentrations were measured and adjusted to be the same, followed by electrophoresis on a precast gel and then transferred to a polyvinylidene difluoride membrane. After being blocked with 5% BSA, the transferred membranes were incubated at 4°C overnight with anti-iNOS antibody, anti-ALIX antibody, anti-GM130 antibody (Proteintech, Chicago, IL, USA), anti-CD63 antibody, anti-Arg-1 antibody, anti-BSP antibody, anti-COL-1 antibody (Cell Signaling Technology, Danvers, MA, USA), anti-RUNX2 antibody, anti-OSX antibody, or anti-β-actin antibody (Abcam, Cambridge, MA, USA) diluted at 1 : 1000. Subsequently, the membranes were incubated with anti-rabbit or anti-mouse secondary antibodies (ZB-2301 and ZB-2305, Zhongshan Golden Bridge Biotechnology, Beijing, China), which were diluted at 1 : 5000 at room temperature for 1 h. The expression of associated proteins was visualized with a chemiluminescence reagent and analyzed using ImageJ software.

The fixed samples were decalcified with 10% disodium ethylenediamine tetraacetate (EDTA) for 4 weeks. Afterward, the specimens were dehydrated in a graded series of ethanol solutions. After the transparent treatment with xylene, the specimen was embedded in paraffin to obtain paraffin sections with a thickness of 5 μm. Hematoxylin and eosin (H&E) and Masson staining was performed to assess periodontal tissue regeneration. Immunohistochemical staining for iNOS and CD206 was performed to assess the immunomodulatory effects and immunohistochemical staining for COL1 (anti-COL1 antibody, Cell Signaling Technology, #72,026) and OCN were performed to assess the osteogenic effects. The staining of specimens was observed under a microscope and the positive cells per high power field (HPF) were calculated.